Relief Therapeutics Holding SA (SWX: RLF)
Switzerland
· Delayed Price · Currency is CHF 1.830
+0.275 (17.68%)
Sep 4, 2024, 5:19 PM CET
RLF Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 123.01 | 128.57 | 110.45 | 94.64 | 78.79 | 93.62 | Upgrade
|
| Revenue Growth (YoY) | -2.77% | 16.41% | 16.71% | 20.12% | -15.85% | -16.01% | Upgrade
|
| Cost of Revenue | 69.16 | 72.52 | 61.23 | 47.42 | 43.59 | 45.33 | Upgrade
|
| Gross Profit | 53.85 | 56.06 | 49.22 | 47.22 | 35.19 | 48.3 | Upgrade
|
| Selling, General & Admin | 41.62 | 41.64 | 37.68 | 36.24 | 34.61 | 40.48 | Upgrade
|
| Other Operating Expenses | 5.9 | 5.73 | 4.58 | 3.83 | 4.11 | 5.14 | Upgrade
|
| Operating Expenses | 49.22 | 49.01 | 43.71 | 41.59 | 40.11 | 47.34 | Upgrade
|
| Operating Income | 4.63 | 7.04 | 5.51 | 5.63 | -4.92 | 0.96 | Upgrade
|
| Interest Expense | - | -0.15 | -0.14 | -0.16 | -0.18 | -0.06 | Upgrade
|
| Interest & Investment Income | 0.82 | 0.02 | 0 | - | 0.01 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -1.06 | -1.06 | -1.54 | -0.72 | 0.08 | -0.27 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.26 | -0.26 | -0.2 | -0.19 | -0.18 | -0.2 | Upgrade
|
| EBT Excluding Unusual Items | 4.13 | 5.59 | 3.63 | 4.56 | -5.2 | 0.43 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0.01 | 0.11 | -0 | 0.01 | Upgrade
|
| Pretax Income | 4.15 | 5.61 | 3.64 | 4.66 | -5.2 | 0.44 | Upgrade
|
| Income Tax Expense | 0.69 | 0.46 | 0.19 | -0.22 | 0.28 | -0.07 | Upgrade
|
| Earnings From Continuing Operations | 3.45 | 5.15 | 3.45 | 4.88 | -5.48 | 0.51 | Upgrade
|
| Minority Interest in Earnings | 0.44 | 0.74 | -0.02 | -0.06 | - | - | Upgrade
|
| Net Income | 3.89 | 5.89 | 3.43 | 4.82 | -5.48 | 0.51 | Upgrade
|
| Net Income to Common | 3.89 | 5.89 | 3.43 | 4.82 | -5.48 | 0.51 | Upgrade
|
| Net Income Growth | -20.40% | 71.74% | -28.86% | - | - | -86.21% | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 | Upgrade
|
| EPS (Basic) | 3.52 | 5.33 | 3.10 | 4.36 | -4.96 | 0.46 | Upgrade
|
| EPS (Diluted) | 3.52 | 5.33 | 3.10 | 4.36 | -4.96 | 0.46 | Upgrade
|
| EPS Growth | -20.40% | 71.74% | -28.86% | - | - | -86.21% | Upgrade
|
| Free Cash Flow | 4.77 | 6.99 | -6.02 | 13.99 | -0.15 | -17.65 | Upgrade
|
| Free Cash Flow Per Share | 4.32 | 6.32 | -5.45 | 12.66 | -0.14 | -15.97 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 0.500 | - | - | - | Upgrade
|
| Dividend Growth | 100.00% | 100.00% | - | - | - | - | Upgrade
|
| Gross Margin | 43.78% | 43.60% | 44.56% | 49.90% | 44.67% | 51.59% | Upgrade
|
| Operating Margin | 3.76% | 5.48% | 4.99% | 5.95% | -6.24% | 1.02% | Upgrade
|
| Profit Margin | 3.17% | 4.58% | 3.10% | 5.09% | -6.95% | 0.55% | Upgrade
|
| Free Cash Flow Margin | 3.88% | 5.43% | -5.45% | 14.78% | -0.19% | -18.85% | Upgrade
|
| EBITDA | 5.96 | 8.32 | 6.65 | 6.84 | -3.83 | 2.28 | Upgrade
|
| EBITDA Margin | 4.85% | 6.47% | 6.02% | 7.23% | -4.87% | 2.43% | Upgrade
|
| D&A For EBITDA | 1.33 | 1.28 | 1.14 | 1.22 | 1.09 | 1.32 | Upgrade
|
| EBIT | 4.63 | 7.04 | 5.51 | 5.63 | -4.92 | 0.96 | Upgrade
|
| EBIT Margin | 3.76% | 5.48% | 4.99% | 5.95% | -6.24% | 1.02% | Upgrade
|
| Effective Tax Rate | 16.67% | 8.24% | 5.11% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.